CompletedNCT03491384
Cannabinoids, Inflammation and Anxiety
About this title
Read the official source — NCT03491384Observational studyAges 21–70United States
Understand this study
Who was this study for?
This study was for people with anxiety. Listed age limits: 21 years to 70 years. Other eligibility criteria applied.
- Listed locations
- BoulderSee all locations and recruitment
Study information
Study start dateStarted: April 1, 2018
- Recruitment status
- Completed
- Enrollment listed in the registry
- 361
- Sponsor
- University of Colorado, Boulder
- Sponsor type
- University
- Study type
- Observational
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 21 Years to 70 Years
- Official registry ID
- NCT03491384
- Official title
Show the full official title
Novel Approaches to Understanding the Role of Cannabinoids and Inflammation in Anxiety
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Boulder
Questions about this study
Who is behind this study?
The study sponsor is University of Colorado, Boulder, a university.
Did this study involve medication?
Yes. The study involved medication, including Cannabis (smoked flower, ingested edible).
Who was this study for?
This study was for people with anxiety. Listed age limits: 21 years to 70 years. Other eligibility criteria applied.
